Cargando…
The prevention of chemotherapy induced peripheral neuropathy by concurrent treatment with drugs used for bipolar disease: a retrospective chart analysis in human cancer patients
Peripheral neuropathy is a major adverse effect in the use of chemotherapeutic drugs. In nearly 50% of patients, chemotherapy induced peripheral neuropathy (CIPN) has been reported as irreversible. With increasing numbers of patients surviving treatment as well as increasing duration of survival aft...
Autores principales: | Wadia, Roxanne J., Stolar, Marilyn, Grens, Clarice, Ehrlich, Barbara E., Chao, Herta H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800905/ https://www.ncbi.nlm.nih.gov/pubmed/29484113 http://dx.doi.org/10.18632/oncotarget.23467 |
Ejemplares similares
-
Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
por: Rodwin, Rozalyn L., et al.
Publicado: (2022) -
Metabolic and Anthropometric Influences on Nerve Conduction Parameters in Patients with Peripheral Neuropathy: A Retrospective Chart Analysis
por: Ly, Daniel H M, et al.
Publicado: (2021) -
Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017) -
Chemotherapy-induced peripheral neuropathy. Part II. Prevention
por: Brzeziński, Krzysztof
Publicado: (2012) -
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
por: Starobova, Hana, et al.
Publicado: (2017)